HSP90B1 and colorectal carcinoma: Flow cytometry analysis revealed that GRP94 IgG can specifically recognize GRP94 binding to the surface of various cetuximab-resistant CRC cells, such as HT-29, LoVo, HCT-8, and HCT116 cells.